Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 148

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 148
---
 |

| * | Less than one percent |

| (1) | This table is based upon information supplied by officers, directors and principal shareholders and Schedules                                                                                                                                         
 13D and 13G and Forms 3 and 4 filed with the SEC. Unless otherwise indicated in the footnotes to this table and subject to community property laws where applicable, we believe that each of the shareholders named in this table has sole voting and 
 investment power with respect to the shares indicated as beneficially owned. Applicable percentages are based on 43,108,362 shares outstanding on the Record Date, adjusted as required by rules promulgated by the SEC.                              |

| (2) | Consists of (a) 5,309,432 Common Shares held by Biotechnology Value Fund, L.P. (“BVF”); (b)                                                                                                                                       
 4,308,573 Common Shares held by Biotechnology Value Fund II, L.P. (“BVF2”); (c) 548,938 Common Shares held by Biotechnology Value Trading Fund OS LP (“Trading Fund OS”); and (d) 166,657 Common Shares held in a certain managed 
 account (the “Partners Managed Account”) managed by BVF Partners L.P. (“BVF Partners”). BVF I GP LLC (“BVF GP”), as the general partner of BVF, may be deemed to beneficially own the Common Shares beneficially                  
 owned by BVF. BVF II GP LLC (“BVF2 GP”), as the general partner of BVF2, may be deemed to beneficially own the Common Shares beneficially owned by BVF2. BVF Partners                                                             |

91

| OS Ltd (“Partners OS”), as the general partner of Trading Fund OS, may be deemed to beneficially own the Common Shares beneficially owned by Trading Fund OS. BVF GP Holdings LLC                                                                      
 (“BVF GPH”), as the sole member of each of BVF GP and BVF2 GP, may be deemed to beneficially own the Common Shares beneficially owned in the aggregate by BVF and BVF2. BVF Partners, as the investment manager of BVF, BVF2, Trading Fund OS          
 and the Partners Managed Account, may be deemed to beneficially own the Shares beneficially owned in the aggregate by BVF, BVF2, Trading Fund OS, and the Partners Managed Account. BVF Inc., as the general partner of BVF Partners, may be deemed to 
 beneficially own the Common Shares